BLS Pharmaceuticals Limited (BLS.AX)
BLS Pharmaceuticals Limited operates in the Specialty Business Services industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.94, up 1.61% on the session, giving a market capitalisation of $216.5M. Its beta of 0.62 implies it has historically moved less than the broad market.
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.